Arq Neuropsiquiatr
March 2019
Unlabelled: It is currently unknown how genetic factors may influence the clinical course of multiple sclerosis (MS).
Objective: We examined the impact of CIITA polymorphisms -168A/G (rs3087456) and +1614G/C (rs4774) on the risk of disability progression, severity and on responses to first-line immunomodulator treatments.
Methods: Genomic DNA was extracted from blood samples.
Background: The HLA-DR15 extended haplotype HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 comprises the strongest genetic risk factor for multiple sclerosis (MS). The aim of this work was to investigate whether HLA-DR15 alleles were significantly associated with the susceptibility to MS familial forms (MSf) in an admixed Brazilian population.
Methods: Association analyses between DR15 and the clinical and demographic variables were made.